Cogent Biosciences Inc
(NAS:COGT)
$
38.91
-2.41 (-5.83%)
Market Cap: 6.65 Bil
Enterprise Value: 6.09 Bil
PE Ratio: 0
PB Ratio: 12.24
GF Score: 30/100 
Cogent Biosciences Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 01:30PM GMT
Release Date Price:
$11.5
(-1.71%)
Eun Yang
(Trades, Portfolio) LLC - Analyst
Good evening, everyone. This is Eun Yang, a biotech analyst with Jefferies. I'm happy to have a fireside chat with Cogent CEO, Andy Robbins.
Andy, before we start the Q&A, could you give us a quick overview of what Cogent does?
Andy Robbins
Cogent Biosciences, Inc. - CEO & President
Sure then. Eun, thanks so much for inviting us to the conference today. Happy to be here even with a smog. So hopefully, excuse my gravelly throat today.
Before I do the intro, just to remind folks for a better and more full characterization of risks to take a look at our SEC disclosures as I probably will be making some forward-looking statements today.
So for those that aren't as familiar with the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers